Outsourced Pharma Editorial Board

Charlene Banard
Chief Technical Officer               Atara Biotherapeutics

Darren Dasburg
CEO, TreeCo 
CBO, CRISPR Biotech

Joanne Beck, Ph.D.
Chief Technology Officer
Aerium Therapeutics 

Marilyn Bruno
CEO
Aequor, Inc.
 

Joseph W. Graskemper
Founder & Principal
Pathways Pharma Consulting, LLC
 

Jana Spes, M.Sc., MBA
Principal
JT Biopharma Partners, LLC  

Steven Goodman
 Executive Director, AAV Process Development and Manufacturing
Vertex Pharmaceuticals

Chuck Forsaith
Vice President - Healthcare Distribution Alliance, 
Pharmaceutical Cargo Security Coalition

James M. Mackay
President and Chief Executive Officer, Aristea Therapeutics

Todd Mabe
VP of GMP Quality
Akouos, Inc.
 

Lisa A. Wyman
SVP, Technical Operations & Quality
Generate Biomedicines
 

Anand Ekambaram
Executive Director
CEPI (Coalition for Epidemic Preparedness Innovations)

Vin Kosewski
SVP Manufacturing & Supply Chain Management
Kala Pharmaceuticals, Inc.

Firelli Alonso, Ph.D.
Senior Director, Biotherapeutics & Vaccine Outsourcing
Pfizer

Bikash Chatterjee
President and CSO
Pharmatech Associates

Shawn Eisenberg
    VP, Biologics CMC                 Acelyrin, Inc.

Doug Bakan
Exec VP, Tech Ops and Quality,
Ventyx Biosciences

Brian James
COO and Managing Director,
Rondaxe

Mark Butchko
Senior Director of Quality Assurance,
Eli Lilly and Company

Roger Graben
President
Vitruvias Therapeutics, Inc.

Sesha Neervannan
Chief Operating Officer
Tarsus Pharmaceuticals, Inc
 

Praveen Prasanna
Senior Director, External Manufacturing
Verve Therapeutics

Robert P. Discordia, Ph.D
Founder, President & CEO
Avanzarx Pharmaceuticals, LLC
 

Ravi Kiron
Head BioPharma External Innovation
EMD Serono, Inc.

Michael Mulkerrin
VP, Head of CMC
ADC Therapeutics

David A. Dodd
Chairman, CEO
GeoVax Labs, Inc.

Tony Sampognaro
Director of CMC Project Management
Stoke Therapeutics

Vadim Klyushnichenko, Ph.D.
VP Pharmaceutical Development & Quality
California Institute for Biomedical Research (Calibr)

Scott Zook
Senior Vice President Global Manufacturing
Primmune Therapeutics
 

Kim K. Burson, Ph.D.
Head of Quality Assurance and Quality Control
Denali Therapeutics, Inc.